Tandem Diabetes Care (TNDM) Non-Current Deffered Revenue (2013 - 2026)

Tandem Diabetes Care (TNDM) has 12 years of Non-Current Deffered Revenue data on file, last reported at $8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 18.91% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (down 18.91% YoY), and the FY2025 full-year result was $8.5 million, down 18.95% from the prior year.
• Non-Current Deffered Revenue for Q1 2026 stood at $8.0 million, down from $8.5 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $19.1 million in Q3 2022 and bottomed at $8.0 million in Q1 2026.
• The 5-year median for Non-Current Deffered Revenue is $12.3 million (2024), against an average of $13.0 million.
• The widest annual swing landed in 2022, when Non-Current Deffered Revenue dropped 0.39%; it then dropped 26.4% in 2023.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $16.9 million in 2022, then decreased by 21.0% to $13.3 million in 2023, then fell by 21.57% to $10.5 million in 2024, then slipped by 18.95% to $8.5 million in 2025, then decreased by 5.66% to $8.0 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $8.0 million (Q1 2026), $8.5 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.

Peer Comparison